Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Sunday, November 02, 2014 10:49:11 AM
bullish
cci(50) crosses 100 upwards
http://stockcharts.com/school/doku.php?st=cci&id=chart_school:technical_indicators:commodity_channel_index_cci
bull flag breakout
$KPTI recent news/filings
## source: finance.yahoo.com
Thu, 30 Oct 2014 12:00:00 GMT ~ Karyopharm to Report Third Quarter 2014 Financial Results on November 10, 2014
[GlobeNewswire] - NEWTON, Mass. -- Karyopharm Therapeutics Inc. , a clinical-stage pharmaceutical company today announced it will report third quarter 2014 financial results on Monday, November 10, 2014. Karyopharm's management ...
read full: http://finance.yahoo.com/news/karyopharm-report-third-quarter-2014-120000529.html
*********************************************************
Mon, 27 Oct 2014 12:12:52 GMT ~ Karyopharm Expands Global Presence With European Subsidiary
[at noodls] - Experienced International Clinical Operations Executive, Ran Frenkel, Appointed Executive Vice President, Worldwide Clinical Development NEWTON, Mass., Oct. 27, 2014 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics ...
read full: http://www.noodls.com/view/437F747CF46EA4AFD00AEEA755A51D83D7D4B2A1
*********************************************************
Mon, 27 Oct 2014 12:00:00 GMT ~ Karyopharm Expands Global Presence With European Subsidiary
[GlobeNewswire] - NEWTON, Mass. -- Karyopharm Therapeutics Inc. , a clinical-stage pharmaceutical company, announced today that it has expanded its operational footprint with a wholly-owned European subsidiary and appointed ...
read full: http://finance.yahoo.com/news/karyopharm-expands-global-presence-european-120000199.html
*********************************************************
Fri, 24 Oct 2014 10:41:26 GMT ~ Why Karyopharm Therapeutics (KPTI) Stock Might be a Great Pick
read full: http://finance.yahoo.com/news/why-karyopharm-therapeutics-kpti-stock-104126511.html
*********************************************************
Mon, 20 Oct 2014 12:35:39 GMT ~ Merrill Lynch’s 5 Destroyed Biotech Stocks With 100% or More Upside Potential
read full: http://247wallst.com/healthcare-business/2014/10/20/merrill-lynchs-5-destroyed-biotech-stocks-with-100-or-more-upside-potential/
*********************************************************
$KPTI charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$KPTI company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/KPTI/company-info
Ticker: $KPTI
OTC Market Place: Not Available
CIK code: not found
Company name: Karyopharm Therapeutics Inc.
Incorporated In:
$KPTI share structure
## source: otcmarkets.com
Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$KPTI extra dd links
Company name: Karyopharm Therapeutics Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/KPTI/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/KPTI/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=KPTI+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=KPTI+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=KPTI+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/KPTI/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/KPTI/news - http://finance.yahoo.com/q/h?s=KPTI+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/KPTI/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/KPTI/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/KPTI/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/KPTI/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/KPTI/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/KPTI/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/KPTI/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/KPTI/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=KPTI+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/KPTI
DTCC (dtcc.com): http://search2.dtcc.com/?q=Karyopharm+Therapeutics+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Karyopharm+Therapeutics+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Karyopharm+Therapeutics+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/KPTI/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/KPTI
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/KPTI/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/KPTI/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/KPTI/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/KPTI/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/KPTI/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/KPTI/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/KPTI/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=KPTI&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=KPTI
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/KPTI/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=KPTI+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=KPTI+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=KPTI
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=KPTI
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=KPTI+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/KPTI/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=KPTI+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/KPTI.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=KPTI
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/KPTI/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/KPTI/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/KPTI/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/KPTI/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/KPTI
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/KPTI
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/KPTI:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=KPTI
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=KPTI
$KPTI DD Notes ~ http://www.ddnotesmaker.com/KPTI
Recent KPTI News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 08:13:19 PM
- Karyopharm to Participate at the 2024 RBC Capital Markets Global Healthcare Conference • PR Newswire (US) • 05/08/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 11:52:01 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 11:47:54 AM
- Karyopharm Announces Significant Refinancing Transactions and Amended Royalty Agreement Extending Vast Majority of Its Debt Maturities into 2028 and 2029 • PR Newswire (US) • 05/08/2024 11:30:00 AM
- Karyopharm Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress • PR Newswire (US) • 05/08/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2024 08:56:19 PM
- Karyopharm to Report First Quarter 2024 Financial Results on May 8, 2024 • PR Newswire (US) • 05/02/2024 08:30:00 PM
- Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 05/01/2024 08:05:00 PM
- Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting • PR Newswire (US) • 04/24/2024 08:01:00 PM
- Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 04/01/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:14:01 PM
- Karyopharm to Participate at Barclays 26th Annual Global Healthcare and Leerink Partners Global Biopharma Conferences • PR Newswire (US) • 03/06/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 12:41:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 12:40:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 12:39:44 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 12:38:37 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 12:37:44 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 12:36:27 AM
- Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 03/01/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 10:36:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 10:35:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 10:35:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 10:35:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 10:35:22 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM